Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.
Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
‘Absolutely tiny’ Federal obesity funding challenged Questions have been raised about why no weight loss drugs are on the PBS, as research highlights the lack of funding for obesity prevention.
Diabetes medication shortage worsens Access to treatment is becoming increasingly dire for patients, with GPs predicting a shortage of tirzepatide will add to an already long list of supply issues.
Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
Virtual care piloted for pregnant women A new program has launched to urgently connect those with symptoms of pregnancy loss to a midwife, but GPs say they need to be kept in the loop.
Do not initiate new patients on semaglutide: TGA The medication is again in short supply due to off-label prescribing for weight loss, despite only being approved for type 2 diabetes management.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.
TGA warns of online semaglutide scams The medicines regulator has said scams include advertising offers being sent to GPs for distribution to patients.
Why do some people infected with COVID-19 lose their smell? New research suggests there may be a genetic link in people who experience anosmia with COVID infection.